As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B ...
BACKGROUND In 2020, Congress established the Emergency Capital Investment Program (“ECIP” or the “Program”) to encourage ...
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
Pharmacy benefit managers (PBMs) significantly impact GTN revenue through rebates, but patient access issues persist due to ...
Pfizer Inc. (NYSE:PFE) today provided its full-year 2026 guidance(2) while revising its November 4, 2025 full-year 2025 ...
The AHA and several safety-net providers argue that an upcoming mandatory rebate pilot violates administrative law, imposes millions in costs, and threatens patient care in vulnerable communities.
TN's U.S. Rep. Diana Harshbarger (R-01) has introduced the 340B Access Act to ensure savings benefit everyone, including rural residents.
Pharmacy leaders say 2026 is shaping up to be a year defined by financial volatility, regulatory pressure and workforce strain — all intensified by upcoming federal drug pricing reforms. Across ...
With health insurance costs poised to spike for more than a half-million Ohioans, U.S. Sen. Jon Husted offered a compromise. It consists mostly of raising costs or cutting benefits for low and ...
Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York proposal would make things worse. Credit: Getty Images. Millions of New Yorkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback